Quality of life after severe acute pancreatitis: systematic review

Abstract

Background Severe acute pancreatitis, the most severe form of acute pancreatitis, can alter pancreatic morphology, physiology, and function resulting in long-term morbidity, even after a single episode. This review assesses long-term outcomes and quality of life of severe acute pancreatitis. Methods A comprehensive literature review was conducted across MEDLINE, Embase, Scopus, and PubMed electronic databases on 18 January 2021 and updated on 26 April 2022 to ensure no new literature had been omitted. All studies were prospective or retrospective, included adult patients (>18 years) presenting with acute pancreatitis for whom data on long-term outcomes specifically after severe acute pancreatitis were reported. Quantitative and qualitative data extraction and synthesis were carried out and no meta-analysis was performed. Outcome measures included aetiology and mortality of severe acute pancreatitis, length of stay, endocrine and exocrine pancreatic insufficiency, chronic symptoms, and quality of life compared with healthy controls as assessed by validated questionnaires. Results Fourteen retrospective cohort studies were included, for a total of 779 patients, using quality of life questionnaires. The most common aetiology of severe acute pancreatitis was biliary (36 per cent) followed by alcoholic (29 per cent). Mortality rate ranged from 5 to 35 per cent and length of stay ranged from 2 to 367 days. Quality of life was somewhat lower in patients with exocrine insufficiency, but unaffected by endocrine insufficiency or chronic symptoms. Quality of life was more likely to be reduced in the first 4 years but normalize thereafter and was more likely to be negatively affected where alcohol was the aetiology. In four studies, the relationship between disease severity and lower quality of life was investigated, and a significant correlation was found. Conclusion The review shows how a single episode of severe acute pancreatitis can have a variable effect on long-term quality of life, which is different to previous studies showing a strong reduction in quality of life. This could indicate that in current times treatment modalities are more effective.

Nutrition therapy in critically ill patients with severe acute pancreatitis

“…71 A recent systematic review summarized that quality of life was more likely to be reduced in the first 4 years after the index attack, but normalize thereafter. 80 Nutrition therapy, like enhanced protein intake and/or nutrition supplementation with β-Hydroxy-β-methylbutyrate (HMB) post-ICU/hospital stay may benefit this population. A meta-analysis showed that HMB and supplements containing HMB increased muscle mass and strength in a variety of clinical conditions.…”

Status and influencing factors of returning to work 6 months after discharge from hospital with severe acute pancreatitis-a cross-sectional descriptive-analytical study in China

“…Patients with severe acute pancreatitis have a sinister condition, many complications, easy to relapse, the case fatality rate is as high as 5% ~50%, and often need to be admitted to the intensive care unit for treatment (6)(7)(8). It is often accompanied by acute respiratory distress syndrome, renal function impairment, pancreatic encephalopathy, diabetes and other complications, thus extending the length of ICU stay, increasing the readmission rate and mortality (9).…”